WuXi PharmaTech (Cayman), Inc. (ADR) (NYSE:WX)
| CAPS Rating |
|
|---|---|
| Open | $14.03 |
| Previous Close | $14.13 |
| Daily Range | $13.69 - $14.08 |
| 52-Week Range | $10.65 - $19.10 |
| Market Cap | $972.72M |
| P/E Ratio | 8.90 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 271,863 |
| Average Daily Volume | 0 |
How do you think WX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
WX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
WX News and Commentary
- ADR Report: Shares Up As Investors Shrug Off Euro Fears – SmartMoney
- Covidien Spins Off Drug Company: 5 Drug Makers Hedge Funds Want Most – NASDAQ
- Covidien Spins Off Drug Company: 5 Drug Makers Hedge Funds Want Most – The Motley Fool
- Earnings Season: 10 Companies on Next Week's Roster Undervalued by Their Target Prices – The Motley Fool
- WuXi PharmaTech Shares Popped: What You Need to Know – The Motley Fool
- The 9 Top Value-Creating Life Sciences Companies – The Motley Fool
- Can Chinese Biotech Appropriately Diversify Your Portfolio? – Minyanville
- Is Covance a Fast Cash Machine? – The Motley Fool
- How Fast Is the Cash at Charles River Laboratories? – The Motley Fool
- WuXi PharmaTech Beats Estimates on Strong Contract Manufacturing Numbers – SeekingAlpha
- Contract Research (CROs): On the Brink of Recovery – SeekingAlpha
- 12 Stocks With Bearish Momentum Being Sold by Mutual Funds – SeekingAlpha
- Benefit by Imitating Julian Robertson: Bullish on Commodities, China, And Tech – SeekingAlpha
- WuXi PharmaTech on the Right Track With 24% Growth in Revenues – SeekingAlpha
- Wuxi Pharmatech Shares Popped: What You Need to Know – The Motley Fool
- Top 30 Most Undervalued, Underperforming Stocks – SeekingAlpha
- Contrarian Ideas: 19 Deeply Undervalued, Beaten Up Stocks – SeekingAlpha
- Growth Stocks That Analysts Love – SeekingAlpha
- Is Pharmaceutical Product Development Going to Burn You? – The Motley Fool
- 29 BRIC Stocks With Growth Potential – SeekingAlpha

RSS Headlines
Fool UK